Cambridge Trust’s Geron GERN Stock Holding History

Cambridge Trust’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$8.25K	Hold	2,500	–	–	﹤0.01%	588
2023 Q4	$5.28K	Hold	2,500	–	–	﹤0.01%	624
2023 Q3	$5.3K	Hold	2,500	–	–	﹤0.01%	623
2023 Q2	$8.03K	Buy	+2,500	New	+$7.11K	﹤0.01%	615

Other funds holding GERN

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cambridge Trust's GERN Position: Q1 2024 in Review

Cambridge Trust held its Geron (GERN) position steady in Q1 2024 at 2,500 shares worth $8.25K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Cambridge Trust first reported a position in GERN in Q2 2023 and has held it in 4 quarters since. 231 funds tracked by Wall St. Rank hold GERN as of Q1 2024.

Cambridge Trust held 2,500 shares of Geron worth $8.25K as of Q1 2024.
Cambridge Trust left its Geron share count unchanged in Q1 2024.
Geron made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #588 holding.
Cambridge Trust first reported a position in Geron in Q2 2023 and has held it in 4 quarters since.
231 funds tracked by Wall St. Rank held Geron as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.